Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 19 Solid Tumor 18 Breast Neoplasms 14 Sarcoma 13 Head and Neck Neoplasms 13 Colorectal Neoplasms 13 Neoplasms 12 Lymphoma, B-Cell 12 Squamous Cell Carcinoma of Head and Neck 11 Pancreatic Neoplasms 11 Leukemia, Myeloid, Acute 11 Stomach Neoplasms 10 Melanoma 10 Lymphoma 9 Carcinoma, Non-Small-Cell Lung 9 Lung Neoplasms 8 Prostatic Neoplasms 7 Leukemia 7 Burkitt Lymphoma 7 Advanced Solid Tumors 7 Ovarian Neoplasms 6 Hematologic Neoplasms 6 Glioblastoma 6 Recurrence 5 Osteosarcoma 5 Lymphoma, Non-Hodgkin 5 Carcinoma, Hepatocellular 5 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Liver Neoplasms 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × INDUSTRY × Neuritis × Clear all

NCT05291286 2025-01-27

RETRO

Bexion Pharmaceuticals, Inc.

Phase EARLY_PHASE1 Completed

Neuritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡